'Fastest growing segment owing' presentation slideshows

Promising In vitro toxicity testing Market Moves to Next Stage

In vitro toxicity testing Market report provides an extensive analysis of the current trends and highlights the market potential from 2014 to 2022, in terms of value.The market scenario is comprehensively analyzed with respect to the type and end users.

137 views • 8 slides

Companion Diagnostics Market categories the Global market by Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), Technology (PCR, IHC, NGS, ISH), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) & Geography.

71 views • 6 slides

Companion Diagnostics Market categories the Global market by Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), Technology (PCR, IHC, NGS, ISH), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) & Geography.

67 views • 6 slides

Companion Diagnostics Market, By Technology

Companion Diagnostics Market categories the Global market by Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), Technology (PCR, IHC, NGS, ISH), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) & Geography.

66 views • 6 slides

Companion Diagnostics Market for Neurological Disorders, By Country

Companion Diagnostics Market categories the Global market by Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), Technology (PCR, IHC, NGS, ISH), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) & Geography.

64 views • 6 slides

Companion Diagnostics Market for Oncology, By End User

By end user, the market is segmented into pharmaceutical & biopharmaceutical companies, reference laboratories, and other end users. The pharmaceutical and biopharmaceutical companies segment is accounted for the largest share of this market in 2016. This end-user segment is also expected to register the highest CAGR during the forecast period. This is due to the wide use of companion diagnostic kits among pharmaceutical and biopharmaceutical companies, due to their benefits such as high efficiency (the kits enable the selection of the most suitable candidates for clinical trials) and cost reduction. To Know More Visit : http://bit.ly/2GrN4zY

63 views • 6 slides

Companion diagnostics market, by end user

Companion Diagnostics Market categories the Global market by Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), Technology (PCR, IHC, NGS, ISH), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) & Geography. To Know More Visit : http://bit.ly/2GrN4zY

66 views • 6 slides

Global Companion Diagnostics Market worth $6.51 Billion by 2022

The global companion diagnostics market is expected to reach USD 6.51 billion by 2022 from USD 2.17 billion in 2016, at a CAGR of 20.1%.

61 views • 6 slides